HIV Populations
CROI 2016: Option B+ Cuts Mother-to-Child HIV Transmission Dramatically in Malawi
- Details
- Category: Pregnancy & HIV MTCT
- Published on Tuesday, 01 March 2016 00:00
- Written by Carole Leach-Lemens
Among women on antiretroviral therapy (ART) prior to pregnancy, early mother-to-child transmission in Malawi’s Option B+ program compares favorably to transmission rates observed in developed countries, Sundeep Gupta told participants at the Conference on Retroviruses and Opportunistic Infections (CROI 2016) last week in Boston.
CROI 2016: Dolutegravir Is Safe and Highly Effective for Older Children with HIV
- Details
- Category: Children & Adolescents
- Published on Friday, 26 February 2016 00:00
- Written by Carole Leach-Lemens
Dolutegravir (Tivicay) plus an optimized background regimen is safe, well tolerated, and provides virological efficacy in HIV-infected children from 6 to 12 years of age at 48 weeks, Andrew Wiznia, presenting on behalf of the IMPAACT1093 study group, told participants at the Conference on Retroviruses and Opportunistic Infections (CROI 2016) this week in Boston.
Health Officials Urge Broader PrEP Use After 4 More HIV Cases Found in Indiana County
- Details
- Category: People Who Inject Drugs
- Published on Friday, 12 February 2016 00:00
- Written by Indiana State Department of Health
An additional 4 new cases of HIV in rural Scott County -- bringing the total to 188 -- have prompted the Indiana State Department of Health to urge people at risk for infection to talk to their healthcare providers about pre-exposure prophylaxis or PrEP, according to a recent announcement.
NHPC 2015: High Rates of HIV Found Among Trans Women
- Details
- Category: Transgender People
- Published on Tuesday, 16 February 2016 00:00
- Written by HIVandHepatitis.com
Although transgender people -- especially trans women of color -- have among the higher rates of HIV infection, this population has not been adequately studied. Many HIV prevention studies have miscategorized transgender women as men who have sex with men, and there has been little specific research on HIV among trans men.
Meta-Analysis Shows Women Are Under-Represented in HIV Clinical Trials
- Details
- Category: Women & HIV
- Published on Friday, 12 February 2016 00:00
- Written by Roger Pebody
Less than a quarter of people taking part in clinical trials for antiretroviral medications are women, potentially limiting the generalizability of findings, according to a systematic review published in the February 1 edition of the Journal of Acquired Immune Deficiency Syndromes.
Web Design and Development by